Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

D. Cortinovis; R. Chiari; A. Catino; F. Grossi; F.D.E. Marinis; F. Sperandi; F. Piantedosi; M. Vitali; H.J. Soto Parra; M.R. Migliorino; C. Tondini; D. Tassinari; A. Frassoldati; F. Verderame; A. Pazzola; F. Cognetti; G. Palmiotti; P. Marchetti; A. Santoro; D. Giannarelli; F. Colonese; A. Delmonte

doi:10.21873/anticanres.13590

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

D. Cortinovis, R. Chiari, A. Catino, F. Grossi, F.D.E. Marinis, F. Sperandi, F. Piantedosi, M. Vitali, H.J. Soto Parra, M.R. Migliorino, C. Tondini, D. Tassinari, A. Frassoldati, F. Verderame, A. Pazzola, F. Cognetti, G. Palmiotti, P. Marchetti, A. Santoro, D. GiannarelliF. Colonese, A. Delmonte

Research output: Contribution to journal › Article

Original language	Italian
Pages (from-to)	4265-4271
Number of pages	7
Journal	Anticancer Research
Volume	39
Issue number	8
DOIs	https://doi.org/10.21873/anticanres.13590
Publication status	Published - 2019

Cite this

Cortinovis, D., Chiari, R., Catino, A., Grossi, F., Marinis, F. D. E., Sperandi, F., Piantedosi, F., Vitali, M., Soto Parra, H. J., Migliorino, M. R., Tondini, C., Tassinari, D., Frassoldati, A., Verderame, F., Pazzola, A., Cognetti, F., Palmiotti, G., Marchetti, P., Santoro, A., ... Delmonte, A. (2019). Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases. Anticancer Research, 39(8), 4265-4271. https://doi.org/10.21873/anticanres.13590

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases. / Cortinovis, D.; Chiari, R.; Catino, A.; Grossi, F.; Marinis, F.D.E.; Sperandi, F.; Piantedosi, F.; Vitali, M.; Soto Parra, H.J.; Migliorino, M.R.; Tondini, C.; Tassinari, D.; Frassoldati, A.; Verderame, F.; Pazzola, A.; Cognetti, F.; Palmiotti, G.; Marchetti, P.; Santoro, A.; Giannarelli, D.; Colonese, F.; Delmonte, A.

In: Anticancer Research, Vol. 39, No. 8, 2019, p. 4265-4271.

Research output: Contribution to journal › Article

Cortinovis, D, Chiari, R, Catino, A , Grossi, F, Marinis, FDE, Sperandi, F, Piantedosi, F, Vitali, M, Soto Parra, HJ, Migliorino, MR, Tondini, C, Tassinari, D, Frassoldati, A, Verderame, F, Pazzola, A, Cognetti, F, Palmiotti, G, Marchetti, P, Santoro, A , Giannarelli, D, Colonese, F & Delmonte, A 2019, 'Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases', Anticancer Research, vol. 39, no. 8, pp. 4265-4271. https://doi.org/10.21873/anticanres.13590

Cortinovis, D. ; Chiari, R. ; Catino, A. ; Grossi, F. ; Marinis, F.D.E. ; Sperandi, F. ; Piantedosi, F. ; Vitali, M. ; Soto Parra, H.J. ; Migliorino, M.R. ; Tondini, C. ; Tassinari, D. ; Frassoldati, A. ; Verderame, F. ; Pazzola, A. ; Cognetti, F. ; Palmiotti, G. ; Marchetti, P. ; Santoro, A. ; Giannarelli, D. ; Colonese, F. ; Delmonte, A. / Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases. In: Anticancer Research. 2019 ; Vol. 39, No. 8. pp. 4265-4271.

@article{78f74b90c17b4c1e8b618718f30eb730,

title = "Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases",

author = "D. Cortinovis and R. Chiari and A. Catino and F. Grossi and F.D.E. Marinis and F. Sperandi and F. Piantedosi and M. Vitali and {Soto Parra}, H.J. and M.R. Migliorino and C. Tondini and D. Tassinari and A. Frassoldati and F. Verderame and A. Pazzola and F. Cognetti and G. Palmiotti and P. Marchetti and A. Santoro and D. Giannarelli and F. Colonese and A. Delmonte",

note = "Export Date: 25 February 2020",

year = "2019",

doi = "10.21873/anticanres.13590",

language = "Italian",

volume = "39",

pages = "4265--4271",

journal = "Anticancer Research",

issn = "0250-7005",

publisher = "International Institute of Anticancer Research",

number = "8",

}

TY - JOUR

T1 - Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

AU - Cortinovis, D.

AU - Chiari, R.

AU - Catino, A.

AU - Grossi, F.

AU - Marinis, F.D.E.

AU - Sperandi, F.

AU - Piantedosi, F.

AU - Vitali, M.

AU - Soto Parra, H.J.

AU - Migliorino, M.R.

AU - Tondini, C.

AU - Tassinari, D.

AU - Frassoldati, A.

AU - Verderame, F.

AU - Pazzola, A.

AU - Cognetti, F.

AU - Palmiotti, G.

AU - Marchetti, P.

AU - Santoro, A.

AU - Giannarelli, D.

AU - Colonese, F.

AU - Delmonte, A.

N1 - Export Date: 25 February 2020

PY - 2019

Y1 - 2019

UR - http://ar.iiarjournals.org/content/40/2/1183.7.long

U2 - 10.21873/anticanres.13590

DO - 10.21873/anticanres.13590

M3 - Articolo

VL - 39

SP - 4265

EP - 4271

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 8

ER -

Access to Document

10.21873/anticanres.13590

Projects

Istituto Scientifico Romagnolo - TERAPIE INNOVATIVE, TRIALS DI FASE I-III E DI STRATEGIA TERAPEUTICA BASATI SU MODELLI PRECLINICI, MECCANISMI ONCO-IMMUNOLOGICI, NANOVETTORI

Project: Other project

Italian cohort of the nivolumab EAP in squamous NSCLC: Efficacy and safety in patients with CNS metastases

Cite this

Access to Document

Related content

Projects

Istituto Scientifico Romagnolo - TERAPIE INNOVATIVE, TRIALS DI FASE I-III E DI STRATEGIA TERAPEUTICA BASATI SU MODELLI PRECLINICI, MECCANISMI ONCO-IMMUNOLOGICI, NANOVETTORI